UNSPSC 51391739: Salmeterol

This classification denotes a bronchodilator with the molecular formula C25H37NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2I4BC502BT, chemically known as 1,3-benzenedimethanol, 4-hydroxy-alpha(sup 1)-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-, (+-)- but generally known as salmeterol, which bears US NIH Compound Identifier 5152. European Medicines Agency schedules Salmeterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10430MIG.

UNSPSC 51391739 Salmeterol is a Commodity code that designates a specific pharmaceutical product—a long-acting beta-2 agonist bronchodilator used in asthma and chronic obstructive pulmonary disease treatment. State and local procurement activity under this code, however, shows a significant mismatch between the nominal scope and the work actually being solicited. The single recent opportunity in the dataset involves naloxone (an opioid-overdose reversal agent) and drug deactivation systems, neither of which falls within the salmeterol therapeutic category. The issuing bodies pursuing pharmaceuticals at this code level include county health departments and community health systems; salmeterol procurement itself typically flows through state Medicaid purchasing, pharmacy benefit managers, or health-system formulary agreements rather than open competitive bidding processes. The sourcing pattern reflects the reality that individual commodity codes for specific drugs often see limited state and local RFP or IFB activity, with most volume consolidated through statewide or regional cooperative purchasing vehicles.

Geographically, the recent opportunities block shows activity originating from Florida (specifically Seminole County), though the naloxone opportunity cited does not represent genuine salmeterol procurement. Seminole County, Florida released IFB 60459723LAS on June 30, 2026 (posted date), with a response deadline of July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford. While this notice is tagged to the salmeterol code, the actual procurement involves opioid-emergency response supplies unrelated to asthma or COPD medication. Business development professionals should treat this code as showing minimal current relevant activity; opportunities for salmeterol supply typically emerge through state health department formulary updates, Medicaid managed-care RFQs, or school and university health center purchasing rather than as standalone competitive bids at the commodity level.